Coles N Anthony's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Nov 9, 2023
- Accession no.
- 0000950170-23-062217
- Filed
- Nov 9, 2023
- Trade date
- Nov 7-8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $680.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coles N AnthonyCIK 0001197018 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | MOption exerciseAcquired | +27,076 | $3.50 | +$94,766 | 29,780 | Direct | |
| Nov 7, 2023 | Common Stock | SSaleDisposed | −27,076 | $25.02 | −$677,441.52 | 2,704 | Direct | |
| Nov 8, 2023 | Common Stock | MOption exerciseAcquired | +100 | $3.50 | +$350 | 2,804 | Direct | |
| Nov 8, 2023 | Common Stock | SSaleDisposed | −100 | $25.16 | −$2,516 | 2,704 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | MOption exerciseDisposed | −27,076 | $0.00 | $0 | 2,525,341 | Direct | |
| Nov 8, 2023 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 2,525,241 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.